Precision Biosciences Inc SEC filings DTIL
Precision Biosciences Inc has 606 filings in SEC EDGAR's recent list, going back to Mar 15, 2006. Its latest annual report, Form ARS, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (other events). The company's fiscal year ends on May 21.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jan 7, 2026 | — |
| CORRESP | Letter to the SEC | Jan 5, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 2, 2026 | — |
| EFFECT | Filing | Jun 15, 2023 | — |
| CORRESP | Letter to the SEC | Jun 13, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2023 | — |
| EFFECT | Filing | Jun 11, 2020 | — |
| CORRESP | Letter to the SEC | Jun 9, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 9, 2020 | — |
| CT ORDER | Filing | Mar 28, 2019 | — |
| EFFECT | Filing | Mar 27, 2019 | — |
| CORRESP | Letter to the SEC | Mar 25, 2019 | — |
| CORRESP | Letter to the SEC | Mar 25, 2019 | — |
| CERT | Filing | Mar 25, 2019 | — |
| 8-A12B | Filing | Mar 19, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 18, 2019 | — |
| D | Filing | Mar 15, 2019 | — |
| CORRESP | Letter to the SEC | Mar 13, 2019 | — |
| CORRESP | Letter to the SEC | Mar 8, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 6, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 22, 2019 | — |
| DRSLTR | Filing | Feb 21, 2019 | — |
| DRS/A | Filing | Feb 21, 2019 | — |
| DRSLTR | Filing | Dec 28, 2018 | — |
| DRS/A | Filing | Dec 28, 2018 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2018 | — |
| DRS | Filing | Oct 19, 2018 | — |
| D | Filing | Jun 8, 2018 | — |
| D | Filing | May 12, 2015 | — |
| REGDEX | Auto-generated paper document | Mar 15, 2006 | — |
Showing 30 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- DTIL (Nasdaq)
- Fiscal year ends
- May 21
- Incorporated in
- DE
- Headquarters
- Durham, NC
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1357874
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.